Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
about
Engineering and Evolution of Molecular Chaperones and Protein Disaggregases with Enhanced ActivityPrecision medicine in spinocerebellar ataxias: treatment based on common mechanisms of diseaseThe nucleotide exchange factors of Hsp70 molecular chaperonesDirect and Propagated Effects of Small Molecules on Protein-Protein Interaction NetworksTargeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseasesStructure and function of Hip, an attenuator of the Hsp70 chaperone cycleThe struggle by Caenorhabditis elegans to maintain proteostasis during aging and diseaseEngineering enhanced protein disaggregases for neurodegenerative diseaseA small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophyHsp70-Bag3 interactions regulate cancer-related signaling networksHSPA8/HSC70 chaperone protein: structure, function, and chemical targeting.Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.Inhibitors of difficult protein-protein interactions identified by high-throughput screening of multiprotein complexes.The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solutionSmall-molecule inhibitors of protein-protein interactions: progressing toward the reality.Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology.Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy.Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model.A model in which heat shock protein 90 targets protein-folding clefts: rationale for a new approach to neuroprotective treatment of protein folding diseasesDown-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.An RNA aptamer specific to Hsp70-ATP conformation inhibits its ATPase activity independent of Hsp40.pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomersAlleviating neurodegeneration in Drosophila models of PolyQ diseases.The Chemical Biology of Molecular Chaperones--Implications for Modulation of ProteostasisTargeting protein aggregation for the treatment of degenerative diseasesFluorescence Turn-On Folding Sensor To Monitor Proteome Stress in Live Cells.Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease.Allosteric heat shock protein 70 inhibitors block hepatitis C virus assemblyMechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.Engineering therapeutic protein disaggregases.Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels.A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy.New hope for therapy in neurodegenerative diseases.The Aqueous Extract of Rhizome of Gastrodia elata Protected Drosophila and PC12 Cells against Beta-Amyloid-Induced Neurotoxicity.Trinucleotide repeats and protein folding and disease: the perspective from studies with the androgen receptor.Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine DiseaseAssociation of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?
P2860
Q26750800-0A78DB6E-FC85-462D-B6A8-354A8E352CE4Q26764958-BF17137A-38A1-46EA-963E-901F929E192CQ26766367-9EA87EC2-8888-4D6E-A655-7C6379E302F0Q26784027-58A80634-4640-4473-BB38-70315DE374DCQ26859909-4A704ED9-3919-4AC1-9FF0-E5364F92C551Q27685147-05C76D87-2011-41AD-BF14-C4983F61FF6BQ28069294-7234668C-0554-4631-8E83-3384A4284AAFQ28083809-2E7EFA24-E6AC-4C25-86E7-550C8D7758B7Q28391475-46643161-F2EF-4724-8B55-261F6D666DAEQ30009385-60F7E733-E9F0-4353-BE8D-FB23E1403DD7Q30354473-6018A71B-D88B-4FA1-9127-9668C928C331Q30405294-29C8DF33-96CE-4629-BE44-9F663E9894F9Q30405382-E80955BB-1143-49FF-90C9-34C280AE2261Q30546915-AE73B6B6-D777-4CDA-8F1D-9D15C7C838D6Q33980214-11FF272D-C6BE-40EA-8CAF-AA30020E95CBQ34263719-0330CD9F-0DF0-449C-991C-89981CA54B9EQ34519909-07A089A5-931F-4EA0-B9D2-28701EEF13ACQ34673417-E4F6AF67-6D01-4FEE-A893-5B0C42D975B7Q34988081-8A2FD978-4A98-4FE0-B764-B7B5B772BE68Q35053633-C705EB1F-0968-48F9-AFAC-6780A34A9E13Q35063586-B0EE3102-B423-435C-B4DF-B0062C04C270Q35224117-F1674027-C183-4AA8-BB5F-68D0A2238E2BQ35590322-EE8CBBAB-3B4C-4071-BBAA-0C609FF6A04DQ36003663-66D64C74-FB58-496F-B6E5-82DE2FA7CFE7Q36059002-74DE2850-E76A-4FAC-A1F2-17670381BD81Q36235980-6B6D8B64-4CA4-401C-A509-EC458AA3CAE3Q36584714-7B9C7A64-3DCF-406E-846F-585FADA0AB44Q36655158-F0E22C30-866A-4940-A2A2-095A7C5546D9Q36803472-E2188A91-03F8-4D59-B54F-F93ACE1ED8D2Q36844932-29545EBA-6C79-4902-B496-4A06BF0C0249Q36896295-02A4CEFC-F240-44EA-AB77-35520A64DD54Q36945826-8A2DB3C5-CF1E-4ED8-8FE8-C88DBCF8DE25Q37004163-29CC0765-8071-4580-A72A-C79E7A8893EAQ37107539-1FC16C27-AC6B-47F5-A720-63D4E73753F1Q37214521-DEB66019-50D8-46DE-8B59-D1561B970E83Q37224880-149EDB26-1C9B-49E1-B28C-9F538257866BQ37474263-58C437CA-B947-49D6-A848-001967C70D48Q37572139-DC7CC226-FE32-4256-AD22-FE51A4CC66AFQ37714440-A7809F3A-CA12-454E-9EFE-678180D78D24Q38149753-E2452956-94DC-4342-9717-5729B5F75441
P2860
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@ast
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@en
type
label
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@ast
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@en
prefLabel
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@ast
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@en
P2093
P2860
P356
P1476
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
@en
P2093
Adrienne M Wang
Andrew P Lieberman
Catherine A Collins
Diane E Merry
Hwei-Ming Peng
Jason E Gestwicki
Jason P Chua
Susan Klinedinst
Tomoko Komiyama
William B Pratt
P2860
P2888
P304
P356
10.1038/NCHEMBIO.1140
P577
2012-12-09T00:00:00Z